A novel hybrid method with convergence analysis for approximation of HTLV-I dynamics model. [PDF]
Molavi-Arabshahi M +2 more
europepmc +1 more source
The HTLV-I oncoprotein Tax inactivates the tumor suppressor FBXW7. [PDF]
Bellon M, Yeh C-h, Bai XT, Nicot C.
europepmc +1 more source
NF-κB1 deficiency promotes macrophage-derived adrenal tumors but decreases neurofibromas in HTLV-I LTR-Tax transgenic mice. [PDF]
Song X, Qu Z.
europepmc +1 more source
Evaluation of Elecsys HTLV-I/II assay in comparison with ARCHITECT rHTLV-I/II assay with Korean samples. [PDF]
Yun SG, Kim SW, Sohn JY, Cho Y.
europepmc +1 more source
Molecular Epidemiology and Phylogenetic Analysis of HTLV-1 in HIV-1-infected Patients in Tehran, Iran. [PDF]
Abyar S +5 more
europepmc +1 more source
Experiences from Two Decades of HTLV-1/2 Testing in a Low-Prevalence Area in Southern Germany, 2004 to 2024. [PDF]
Korn K +5 more
europepmc +1 more source
Low Prevalence of Human T-Cell Lymphotropic Virus Type 1 (HTLV-1) in a Hospital Triage Population in Tehran During 2024-2025. [PDF]
Letafati A +8 more
europepmc +1 more source
Recommendations for counseling persons infected with human T-lymphotrophic virus, types I and II: The human T-lymphotropic viruses, type I (HTLV-I) and type II (HTLV-II), are closely related but distinct retroviruses that can infect humans.
core
Host genetic determinants of HTLV-1 infection outcomes. [PDF]
Akbarin MM, Farjami Z, Álvarez HR.
europepmc +1 more source

